地塞米松与环磷酰胺冲击治疗儿童过敏性紫癜肾炎91例
参考文献5
-
1程传勋,任桂花,可秋萍,徐靖,王云峰,张虹.麻疹减毒活疫苗配合强的松治疗紫癜性肾炎临床观察[J].临床儿科杂志,1997,15(2):87-88. 被引量:8
-
2潘慧娟,杨魁兰.过敏性紫癜肾炎的免疫学机制[J].国外医学(儿科学分册),2002,29(5):249-251. 被引量:63
-
3赫安娜,王桂梅.抗凝治疗预防紫癜性肾炎发生的临床观察[J].实用儿科临床杂志,2001,16(4):251-251. 被引量:9
-
4牛余宗,刘秀琴,韩林,初建芳.紫癜性肾炎患儿血浆内皮素-1、vWF、D-二聚体的变化及临床意义[J].临床儿科杂志,2001,19(2):96-98. 被引量:11
-
5吉德平 赵相发 李运壁 等.地塞米松和环磷酰胺冲击治疗难治性肾病综合征 42例[J].实用儿科临床杂志Shiyong Erke Linchuang Zazhi,2000,15(2):112-112.
二级参考文献28
-
1冯学斌,刘凤,黄薇,许玉华.儿童过敏性紫癜血液流变学观察[J].中华血液学杂志,1995,16(3):141-141. 被引量:32
-
2田秀巧 窦志艳.小儿过敏性紫癜128例分析[J].河北医药,1995,15(4):289-289.
-
3Egan CA, Taylor TB, Meyer LJ, et al. IgA1 is the major IgA subclass in cutaneous blood vessels in Henoch-Schnolein purpura[J].Br J Dermatol, 1999,14(5):859-862.
-
4Sediva A. Stejskal J, Bartunkova, J, et al. Detection of alpha(beta)-N-acetyl-D-galactosamine-binding sites in kidney-relation to Henoch- Schonlein-associated IgA nephropathy[J]. Folia Biol (Praha),1999,45(4):147-150.
-
5Moja P, Quesnel A, Resseguier V, et al. Is there IgA form gut mucosal origin in the serum of children with Henoch-Schonlein Purpura?[J].Clin Immunol Immunopathol, 1998,86(3):290-297.
-
6Davin JC, Pierard G, Dechenne C, et al. Possible pathogenic role of IgE in Hennoch-Schonlein purpura[J]. Pediatr Nephrol, 1994,8(2):169-171.
-
7Fujieda M, Oishi N, Naruse K, et al. Soluble thrombomodulin and antibodies to bovineglomemlarendothelial cells in patients with HenochSchonlein purpura[J]. Arch Dis Child, 1998,78(3):240-244.
-
8Yang YH, Huang MT, Lin SC, et al. Increased transforming growth factor- beta (TGF- beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schonlein purpura[J]. Clin Exp Immunol, 2000,122(2):285-290.
-
9Sokol DK, Mclntyre JA, short RA, et al. Henoch-Schonlein purpura and stroke: antiphosphatidylethanolamine antibody in CSF and serum[J]. Neurology, 2000,55(9):1379-1381.
-
10Bansal AS, Dwivedi N, Adsett M. Serum and blister fluid cytokines and complement proteins in a patient with Henoch - Schonlein purpura associated with a bullous skin rash[J]. Australas J Dermatol, 1997,38(4): 190-192.
共引文献87
-
1盛凯,牛仙玲,付桂玲.儿童过敏性紫癜131例临床分析[J].中国医药导报,2006,3(32):40-41. 被引量:1
-
2杨秀平,李莉.中西医结合治疗小儿过敏性紫癜疗效观察[J].四川中医,2005,23(1):79-80. 被引量:4
-
3赵美春,王静静,李凤艳,商丽.普鲁卡因加川芎嗪佐治小儿过敏性紫癜42例疗效观察[J].滨州医学院学报,2005,28(2):137-137.
-
4孙彩艳,李建敏.联合应用丙种球蛋白和麻疹减毒活疫苗佐治紫癜性肾炎30例[J].新乡医学院学报,2005,22(4):342-343. 被引量:7
-
5董召斌,吴鹏林.小儿紫癜性肾炎治疗进展[J].安徽医药,2005,9(4):288-289. 被引量:6
-
6王业军,张秋业.过敏性紫癜研究进展[J].齐鲁医学杂志,2005,20(5):457-458. 被引量:18
-
7崔玉霞,刘若英,李实光,杨锡强.过敏性紫癜患儿PBMC表面粘附分子表达、血清抗中性粒细胞胞浆抗体检测情况研究[J].临床儿科杂志,2006,24(1):60-62. 被引量:6
-
8陆燕凤.萘普生治疗腹型过敏性紫癜的疗效观察[J].温州医学院学报,2006,36(1):82-83.
-
9王星,王华,刘玉峰,李振彪,徐学聚.过敏性紫癜患儿急性期细胞免疫功能的变化与肾损害之间的联系[J].中原医刊,2006,33(5):31-32. 被引量:1
-
10于晓晴,傅亮,高进,张铎.转化生长因子与紫癜性肾炎[J].内蒙古医学杂志,2006,38(1):51-54.
-
1郑宇,郭东阳.20例紫癜性肾炎临床分析[J].西南军医,2004,6(3):35-36.
-
2康三洋.环磷酰胺冲击治疗60例难治性肾病综合征的疗效观察[J].内蒙古中医药,2012,31(20):70-70.
-
3唐珊珊.甲基强的松龙、环磷酰胺冲击治疗难治性肾病综合征疗效观察[J].河北医药,2010,32(21):2997-2998. 被引量:8
-
4黎伟,李爱华.环磷酰胺冲击治疗难治性肾病综合征30例疗效观察[J].中国医药导刊,2008,10(9):1393-1393.
-
5杜成雪,米本勇,唐红梅.儿童过敏性紫癜肾炎32例临床分析[J].实用医院临床杂志,2006,3(5):51-51. 被引量:1
-
6李敬来,萧明第.Rapamycin联合供体脾细胞对大鼠移植心脏生存时间的影响[J].临床医学,2008,28(8):101-102.
-
7黄莉,徐瑾,廖蕴华.159例老年急性肾衰竭的临床流行病学[J].中国老年学杂志,2011,31(4):564-566. 被引量:5
-
8万桂莲.小儿过敏性紫癜33例的护理体会[J].中国基层医药,2006,13(10):1758-1759.
-
9郭齐,鹿玲.儿童紫癜性肾炎的免疫治疗进展[J].新医学,2010,41(5):339-341. 被引量:9
-
10代尊昌.环磷酰胺冲击治疗狼疮性肾炎并发狼疮脑的临床疗效[J].海南医学,2005,16(4):112-113. 被引量:3